FDA inspection
Glenmark Pharmaceuticals Limited: FDA inspection ending Sep 20, 2024
FDA inspection 1252922 · No Action Indicated (NAI) · Aurangabad
Key facts
| Inspection ID | 1252922 |
|---|---|
| Firm | Glenmark Pharmaceuticals Limited |
| FEI number | 3009915929 |
| Address | B-25 Midc Shendra |
| City | Aurangabad |
| Country | India |
| Fiscal year | 2024 |
| Inspection end date | Sep 20, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data